Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA
- PMID: 11278520
- DOI: 10.1074/jbc.M009539200
Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA
Abstract
Factor VIII circulates as a noncovalent heterodimer consisting of a heavy chain (HC, contiguous A1-A2-B domains) and light chain (LC). Cleavage of HC at the A1-A2 and A2-B junctions generates the A1 and A2 subunits of factor VIIIa. Although the isolated A2 subunit stimulates factor IXa-catalyzed generation of factor Xa by approximately 100-fold, the isolated HC, free from the LC, showed no effect in this assay. However, extended reaction of HC with factors IXa and X resulted in an increase in factor IXa activity because of conversion of the HC to A1 and A2 subunits by factor Xa. HC cleavage by thrombin or factor Xa yielded similar products, although factor Xa cleaved at a rate of approximately 1% observed for thrombin. HC showed little inhibition of the A2 subunit-dependent stimulation of factor IXa activity, suggesting that factor IXa-interactive sites are masked in the A2 domain of HC. Furthermore, HC showed no effect on the fluorescence anisotropy of fluorescein-Phe-Phe-Arg-factor IXa in the presence of factor X, whereas thrombin-cleaved HC yielded a marked increase in this parameter. These results indicate that HC cleavage by either thrombin or factor Xa is essential to expose the factor IXa-interactive site(s) in the A2 subunit required to modulate protease activity.
Similar articles
-
Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.J Biol Chem. 1995 Apr 14;270(15):8546-52. doi: 10.1074/jbc.270.15.8546. J Biol Chem. 1995. PMID: 7721754
-
The A1 and A2 subunits of factor VIIIa synergistically stimulate factor IXa catalytic activity.J Biol Chem. 1999 May 28;274(22):15401-6. doi: 10.1074/jbc.274.22.15401. J Biol Chem. 1999. PMID: 10336428
-
Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.Blood. 1992 Dec 15;80(12):3120-6. Blood. 1992. PMID: 1467518
-
Factor VIII structure and function.Int J Hematol. 2006 Feb;83(2):103-8. doi: 10.1532/IJH97.05113. Int J Hematol. 2006. PMID: 16513527 Review.
-
Activation of factor VIII and mechanisms of cofactor action.Blood Rev. 2004 Mar;18(1):1-15. doi: 10.1016/s0268-960x(03)00025-0. Blood Rev. 2004. PMID: 14684146 Review.
Cited by
-
Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.BMC Struct Biol. 2010 Feb 25;10:7. doi: 10.1186/1472-6807-10-7. BMC Struct Biol. 2010. PMID: 20184747 Free PMC article.
-
The role of P4-P3' residues flanking Arg336 in facilitating activated protein C-catalyzed cleavage and inactivation of factor VIIIa.Thromb Res. 2011 Nov;128(5):470-6. doi: 10.1016/j.thromres.2011.03.007. Epub 2011 Apr 5. Thromb Res. 2011. PMID: 21470668 Free PMC article.
-
Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.Thromb Haemost. 2014 Sep 2;112(3):495-502. doi: 10.1160/TH14-01-0086. Epub 2014 Jun 5. Thromb Haemost. 2014. PMID: 24899227 Free PMC article.
-
Coagulation factor VIII: biological basis of emerging hemophilia A therapies.Blood. 2024 Nov 21;144(21):2185-2197. doi: 10.1182/blood.2023023275. Blood. 2024. PMID: 39088776 Review.
-
P3-P3' residues flanking scissile bonds in factor VIII modulate rates of substrate cleavage and procofactor activation by thrombin.Biochemistry. 2012 Apr 24;51(16):3451-9. doi: 10.1021/bi300070z. Epub 2012 Apr 10. Biochemistry. 2012. PMID: 22455313 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources